Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10–enhanced MR Imaging: Phase III Safety and Efficacy Study-Reference-Cited by-同舟云学术

Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10–enhanced MR Imaging: Phase III Safety and Efficacy Study

Published:2003-09 Issue:3 Volume:228 Page:777-788
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Anzai Yoshimi,Piccoli Catherine W.,Outwater Eric K.,Stanford William,Bluemke David A.,Nurenberg Pamela,Saini Sanjay,Maravilla Kenneth R.,Feldman David E.,Schmiedl Udo P.,Brunberg James A.,Francis Isaac R.,Harms Steven E.,Som Peter M.,Tempany Clare M.

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2283020872

Reference32 articles.

1. Varallyay P, Nesbit G, Muldoon LL, et al.Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran 10 with a gadolinium chelate in imaging intracranial tumors.AJNR Am J Neuroradiol2002; 23:510-519.

2. MR imaging of phagocytosis in experimental gliomas.

3. Tumoral Distribution of Long-circulating Dextran-coated Iron Oxide Nanoparticles in a Rodent Model

4. MR lymphography: study of a high-efficiency lymphotrophic agent.

5. Experimental lymph node metastases: enhanced detection with MR lymphography.

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferumoxtran-10-enhanced MRI for pre-operative metastatic lymph node detection in pancreatic, duodenal, or periampullary adenocarcinoma;European Radiology;2024-06-22

2. Magnetic Nanoparticles for Biomedical and Imaging Applications;International Journal of Molecular Sciences;2024-05-28

3. Development and validation of a nomogram to predict lymph node metastasis in patients with progressive muscle-invasive bladder cancer;Frontiers in Oncology;2024-05-16

4. Recent nanotheranostic approaches in cancer research;Clinical and Experimental Medicine;2024-01-19

5. Functionalized magnetic nanoparticles for cancer therapy;Functionalized Nanomaterials for Cancer Research;2024